Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about LEGN

Recent news which mentions LEGN

< Previous 1 2 3 4 5 Next >

Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients

July 02, 2024

Assessing Legend Biotech: Insights From 15 Financial Analysts

June 21, 2024

Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst

June 17, 2024

Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?

June 09, 2024

Unveiling 18 Analyst Insights On Legend Biotech

June 04, 2024

Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)

May 14, 2024

LEGN Stock Earnings: Legend Biotech Beats EPS, Misses Revenue for Q1 2024

May 13, 2024

FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies

April 19, 2024

Analyst Ratings For Legend Biotech

April 17, 2024

Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population

April 08, 2024

Unveiling 9 Analyst Insights On Legend Biotech

April 01, 2024

GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy

March 20, 2024

FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer

March 18, 2024

FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers

March 13, 2024

Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session

March 13, 2024

Earnings Scheduled For March 11, 2024

March 11, 2024

Earnings Preview: Legend Biotech

March 08, 2024

Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley

March 07, 2024

What 4 Analyst Ratings Have To Say About Legend Biotech

March 07, 2024

Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment

January 23, 2024

As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?

January 10, 2024

Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024

January 04, 2024

Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback

December 29, 2023

Key Takeaways From Legend Biotech Analyst Ratings

December 19, 2023

Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say

December 11, 2023

Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment

November 20, 2023

Earnings Scheduled For November 20, 2023

November 20, 2023

Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On

November 16, 2023

Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug

October 18, 2023

Analyst Ratings for Legend Biotech

October 18, 2023

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.